RCC Recurrence Linked to Elevated Presurgical Platelet Levels
Platelet levels above 250,000/μL prior to surgery for high-risk renal cell carcinoma are independently associated with a 1.5-fold increase risk for recurrence.
Platelet levels above 250,000/μL prior to surgery for high-risk renal cell carcinoma are independently associated with a 1.5-fold increase risk for recurrence.
Positive surgical margins in patients undergoing partial nephrectomy for cT1b renal cell carcinoma are associated with worse 5-year recurrence-free and overall survival.
Elevated C-reactive protein levels prior to nephrectomy for renal cell carcinoma is associated with an increased risk of renal impairment, a study found.
The 10-year mortality risk from testicular cancer is 12% higher among black men compared with white men.
In a large study of men with grade group 2 or 3 prostate cancer, cancer-specific mortality at 8 years was high at 6% and 11% for active surveillance and watchful waiting patients, respectively.
Preliminary results from TRoMbone pave the way for a full randomized controlled trial.
A study of American men showed that those who adhered to a low-fat diet were twice as likely as men consuming usual diets to have hypogonadism.
In a study, left-sided renal cell carcinoma (RCC) was associated with a 16% to 19% increased risk of dying from the malignancy compared with right-sided RCC.
A study at Memorial Sloan Kettering Cancer Center found that the 5-year probability of dying from bladder cancer following radical cystectomy dropped from 35% to 25%.
By 3 and 6 months, flow rate, post void residual, IPSS, quality of life, and prostate volume improved in patients treated with the Rezum system, which uses convective heating to ablate prostate tissue.